ReP USP - Resultado da busca

Artigo de periodico
Evaluation of continuous tumor-size-based end points as surrogates for overall survival in randomized clinical trials in metastatic colorectal cancer (2019)
Burzykowski, Tomasz; Coart, Elisabeth; Saad, Everardo D; Shi, Qian; Sommeijer, Dirkje W; Bokemeyer, Carsten; Diaz-rubio, Eduardo; Douillard, Jean-Yves; Falcone, Alfredo; Hoff, Paulo Marcelo Gehm
Source: Jama network open. Unidade: FM
Subjects: NEOPLASIAS COLORRETAIS, METÁSTASE NEOPLÁSICA, SOBREVIDA, QUIMIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BURZYKOWSKI, Tomasz et al. Evaluation of continuous tumor-size-based end points as surrogates for overall survival in randomized clinical trials in metastatic colorectal cancer. Jama network open, v. 2, n. 9, 2019Tradução . . Disponível em: https://doi.org/10.1001/jamanetworkopen.2019.11750. Acesso em: 07 nov. 2024.
APA
Burzykowski, T., Coart, E., Saad, E. D., Shi, Q., Sommeijer, D. W., Bokemeyer, C., et al. (2019). Evaluation of continuous tumor-size-based end points as surrogates for overall survival in randomized clinical trials in metastatic colorectal cancer. Jama network open, 2( 9). doi:10.1001/jamanetworkopen.2019.11750
NLM
Burzykowski T, Coart E, Saad ED, Shi Q, Sommeijer DW, Bokemeyer C, Diaz-rubio E, Douillard J-Y, Falcone A, Hoff PMG. Evaluation of continuous tumor-size-based end points as surrogates for overall survival in randomized clinical trials in metastatic colorectal cancer [Internet]. Jama network open. 2019 ; 2( 9):[citado 2024 nov. 07 ] Available from: https://doi.org/10.1001/jamanetworkopen.2019.11750
Vancouver
Burzykowski T, Coart E, Saad ED, Shi Q, Sommeijer DW, Bokemeyer C, Diaz-rubio E, Douillard J-Y, Falcone A, Hoff PMG. Evaluation of continuous tumor-size-based end points as surrogates for overall survival in randomized clinical trials in metastatic colorectal cancer [Internet]. Jama network open. 2019 ; 2( 9):[citado 2024 nov. 07 ] Available from: https://doi.org/10.1001/jamanetworkopen.2019.11750
Artigo de periodico
Individual Patient Data Analysis of Progression-Free Survival Versus Overall Survival As a First-Line End Point for Metastatic Colorectal Cancer in Modern Randomized Trials: Findings From the Analysis and Research in Cancers of the Digestive System Database (2015)
Shi, Qian; Gramont, Aimery de; Grothey, Axel; Zalcberg, John; Chibaudel, Benoist; Schmoll, Hans-Joachim; Seymour, Matthew T.; Adams, Richard; Saltz, Leonard; Goldberg, Richard M.; Punt, Cornelis J. A.; Douillard, Jean-Yves; Hoff, Paulo M.; Hecht, Joel Randolph; Hurwitz, Herbert; Díaz-Rubio, Eduardo; Porschen, Rainer; Tebbutt, Niall C.; Fuchs, Charles; Souglakos, John; Falcone, Alfredo; Tournigand, Christophe; Kabbinavar, Fairooz F.; Heinemann, Volker; Cutsem, Eric Van; Bokemeyer, Carsten; Buyse, Marc; Sargent, Daniel J.
Source: Journal of Clinical Oncology. Unidade: FM
Subjects: NEOPLASIAS COLORRETAIS, PROGNÓSTICO, METÁSTASE NEOPLÁSICA, ESTUDOS RANDOMIZADOS, NEOPLASIAS DO SISTEMA DIGESTÓRIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SHI, Qian et al. Individual Patient Data Analysis of Progression-Free Survival Versus Overall Survival As a First-Line End Point for Metastatic Colorectal Cancer in Modern Randomized Trials: Findings From the Analysis and Research in Cancers of the Digestive System Database. Journal of Clinical Oncology, v. 33, n. 1, p. 22-28, 2015Tradução . . Disponível em: https://doi.org/10.1200/JCO.2014.56.5887. Acesso em: 07 nov. 2024.
APA
Shi, Q., Gramont, A. de, Grothey, A., Zalcberg, J., Chibaudel, B., Schmoll, H. -J., et al. (2015). Individual Patient Data Analysis of Progression-Free Survival Versus Overall Survival As a First-Line End Point for Metastatic Colorectal Cancer in Modern Randomized Trials: Findings From the Analysis and Research in Cancers of the Digestive System Database. Journal of Clinical Oncology, 33( 1), 22-28. doi:10.1200/JCO.2014.56.5887
NLM
Shi Q, Gramont A de, Grothey A, Zalcberg J, Chibaudel B, Schmoll H-J, Seymour MT, Adams R, Saltz L, Goldberg RM, Punt CJA, Douillard J-Y, Hoff PM, Hecht JR, Hurwitz H, Díaz-Rubio E, Porschen R, Tebbutt NC, Fuchs C, Souglakos J, Falcone A, Tournigand C, Kabbinavar FF, Heinemann V, Cutsem EV, Bokemeyer C, Buyse M, Sargent DJ. Individual Patient Data Analysis of Progression-Free Survival Versus Overall Survival As a First-Line End Point for Metastatic Colorectal Cancer in Modern Randomized Trials: Findings From the Analysis and Research in Cancers of the Digestive System Database [Internet]. Journal of Clinical Oncology. 2015 ; 33( 1): 22-28.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1200/JCO.2014.56.5887
Vancouver
Shi Q, Gramont A de, Grothey A, Zalcberg J, Chibaudel B, Schmoll H-J, Seymour MT, Adams R, Saltz L, Goldberg RM, Punt CJA, Douillard J-Y, Hoff PM, Hecht JR, Hurwitz H, Díaz-Rubio E, Porschen R, Tebbutt NC, Fuchs C, Souglakos J, Falcone A, Tournigand C, Kabbinavar FF, Heinemann V, Cutsem EV, Bokemeyer C, Buyse M, Sargent DJ. Individual Patient Data Analysis of Progression-Free Survival Versus Overall Survival As a First-Line End Point for Metastatic Colorectal Cancer in Modern Randomized Trials: Findings From the Analysis and Research in Cancers of the Digestive System Database [Internet]. Journal of Clinical Oncology. 2015 ; 33( 1): 22-28.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1200/JCO.2014.56.5887
Trabalho de evento-resumo periodico
Trial-level association between response-based endpoints (RBEs) and progression-free (PFS)/overall survival (OS) in first-line therapy for metastatic colorectal cancer (mCRC) in the ARCAD database. (2015)
Coart, Elisabeth; Saad, Everardo D.; Shi, Qian; Sommeijer, Dirkje Willemien; Zalcberg, John Raymond; Maughan, Tim; Goldberg, Richard M.; Schmoll, Hans-Joachim; Punt, Cornelis J. A.; Cutsem, Eric Van; Douillard, Jean-Yves; Hoff, Paulo Marcelo; Tebbutt, Niall C.; Fuchs, Charles S.; Falcone, Alfredo; Tournigand, Christophe; De Gramont, Aimery; Sargent, Daniel J.; Burzykowski, Tomasz; Buyse, Marc E.
Source: Journal of Clinical Oncology. Conference titles: Gastrointestinal Cancers Symposium. Unidade: FM
Subjects: TAXA DE SOBREVIVÊNCIA, NEOPLASIAS COLORRETAIS, METÁSTASE NEOPLÁSICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COART, Elisabeth et al. Trial-level association between response-based endpoints (RBEs) and progression-free (PFS)/overall survival (OS) in first-line therapy for metastatic colorectal cancer (mCRC) in the ARCAD database. Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1200/jco.2015.33.3_suppl.666. Acesso em: 07 nov. 2024. , 2015
APA
Coart, E., Saad, E. D., Shi, Q., Sommeijer, D. W., Zalcberg, J. R., Maughan, T., et al. (2015). Trial-level association between response-based endpoints (RBEs) and progression-free (PFS)/overall survival (OS) in first-line therapy for metastatic colorectal cancer (mCRC) in the ARCAD database. Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. doi:10.1200/jco.2015.33.3_suppl.666
NLM
Coart E, Saad ED, Shi Q, Sommeijer DW, Zalcberg JR, Maughan T, Goldberg RM, Schmoll H-J, Punt CJA, Cutsem EV, Douillard J-Y, Hoff PM, Tebbutt NC, Fuchs CS, Falcone A, Tournigand C, De Gramont A, Sargent DJ, Burzykowski T, Buyse ME. Trial-level association between response-based endpoints (RBEs) and progression-free (PFS)/overall survival (OS) in first-line therapy for metastatic colorectal cancer (mCRC) in the ARCAD database. [Internet]. Journal of Clinical Oncology. 2015 ; 33( 3S ):[citado 2024 nov. 07 ] Available from: https://doi.org/10.1200/jco.2015.33.3_suppl.666
Vancouver
Coart E, Saad ED, Shi Q, Sommeijer DW, Zalcberg JR, Maughan T, Goldberg RM, Schmoll H-J, Punt CJA, Cutsem EV, Douillard J-Y, Hoff PM, Tebbutt NC, Fuchs CS, Falcone A, Tournigand C, De Gramont A, Sargent DJ, Burzykowski T, Buyse ME. Trial-level association between response-based endpoints (RBEs) and progression-free (PFS)/overall survival (OS) in first-line therapy for metastatic colorectal cancer (mCRC) in the ARCAD database. [Internet]. Journal of Clinical Oncology. 2015 ; 33( 3S ):[citado 2024 nov. 07 ] Available from: https://doi.org/10.1200/jco.2015.33.3_suppl.666

USP Schools

ReP

Filtros

Authors

Subjects